Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials.

Nan C, Shaefer M, Urbaityte R, Oyee J, Hopking J, Ragone L, Perger T, Win B, Vangerow H, McCoig C, Vannappagari V.

Open Forum Infect Dis. 2018 Apr 20;5(5):ofy086. doi: 10.1093/ofid/ofy086. eCollection 2018 May.

2.

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.

Quercia R, Perno CF, Koteff J, Moore K, McCoig C, St Clair M, Kuritzkes D.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):125-135. doi: 10.1097/QAI.0000000000001660.

3.

Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open-Label, Randomized Study.

Adkison K, Wolstenholme A, Lou Y, Zhang Z, Eld A, Perger T, Vangerow H, Hayward K, Shaefer M, McCoig C.

Clin Pharmacol Ther. 2018 Mar;103(3):402-408. doi: 10.1002/cpt.943. Epub 2017 Dec 11.

4.

[A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011)].

Ortiz-Lana N, Garrote E, Arístegui J, Rementeria J, García-Martínez JA, McCoig C, García-Corbeira P, Devadiga R, Tafalla M.

An Pediatr (Barc). 2017 Dec;87(6):311-319. doi: 10.1016/j.anpedi.2016.10.016. Epub 2017 Mar 28. Spanish.

5.

[Bacterial etiology of acute otitis media in Spain in the post-pneumococcal conjugate vaccine era].

Pumarola F, Salamanca de la Cueva I, Sistiaga-Hernando A, García-Corbeira P, Moraga-Llop FA, Cardelús S, McCoig C, Gómez Martínez JR, Rosell Ferrer R, Iniesta Turpin J, Devadiga R.

An Pediatr (Barc). 2016 Nov;85(5):224-231. doi: 10.1016/j.anpedi.2015.10.016. Epub 2016 Mar 9. Spanish.

6.

Seroprevalence of pertussis amongst healthcare professionals in Spain.

Rodríguez de la Pinta ML, Castro Lareo MI, Ramon Torrell JM, García de Lomas J, Devadiga R, Reyes J, McCoig C, Tafalla M, García-Corbeira P.

Vaccine. 2016 Feb 17;34(8):1109-14. doi: 10.1016/j.vaccine.2015.12.036. Epub 2015 Dec 22.

7.

Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.

Saavedra-Lozano J, McCoig CC, Cao Y, Vitetta ES, Ramilo O.

Antimicrob Agents Chemother. 2004 Aug;48(8):2825-30.

8.

Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.

McCoig C, Castrejón MM, Saavedra-Lozano J, Castaño E, Báez C, Lanier ER, Sáez-Llorens X, Ramilo O.

Pediatr Infect Dis J. 2004 Feb;23(2):114-8.

PMID:
14872175
9.

Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.

Lutsar I, Friedland IR, Jafri HS, Wubbel L, Ahmed A, Trujillo M, McCoig CC, McCracken GH Jr.

J Antimicrob Chemother. 2003 Oct;52(4):651-5. Epub 2003 Sep 1.

PMID:
12951330
10.

Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.

Rodriguez-Cerrato V, McCoig CC, Saavedra J, Barton T, Michelow IC, Hardy RD, Bowlware K, Iglehart J, Katz K, McCracken GH Jr.

Antimicrob Agents Chemother. 2003 Jan;47(1):211-5.

11.

Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy.

McCoig C, Castrejón MM, Castaño E, De Suman O, Báez C, Redondo W, McClernon D, Danehower S, Lanier ER, Richardson C, Keller A, Hetherington S, Sáez-Llorens X, Ramilo O.

J Pediatr. 2002 Jul;141(1):36-44.

PMID:
12091849
12.

An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.

Saavedra-Lozano J, McCoig C, Xu J, Cao Y, Keiser P, Ghetie V, Siliciano RF, Siliciano JD, Picker LJ, Ramilo O, Vitetta ES.

J Infect Dis. 2002 Feb 1;185(3):306-14. Epub 2002 Jan 8.

PMID:
11807712
13.

Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.

Sáez-Llorens X, McCoig C, Feris JM, Vargas SL, Klugman KP, Hussey GD, Frenck RW, Falleiros-Carvalho LH, Arguedas AG, Bradley J, Arrieta AC, Wald ER, Pancorbo S, McCracken GH Jr, Marques SR; Trovan menigitis Study Group.

Pediatr Infect Dis J. 2002 Jan;21(1):14-22. Erratum in: Pediatr Infect Dis J 2002 Mar;21(3):270.

PMID:
11791092
14.

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Rodriguez-Cerrato V, McCoig CC, Michelow IC, Ghaffar F, Jafri HS, Hardy RD, Patel C, Olsen K, McCracken GH Jr.

Antimicrob Agents Chemother. 2001 Nov;45(11):3092-7.

15.

An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro.

McCoig C, Van Dyke G, Chou CS, Picker LJ, Ramilo O, Vitetta ES.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11482-5.

16.

Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.

McCoig CC, Wubbel L, Jafri HS, Lutsar I, Bastero R, Olsen K, Shelton S, Friedland IR, McCracken GH.

J Antimicrob Chemother. 1999 May;43(5):683-8.

PMID:
10382890
17.

Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Ahmed A, Jafri H, Lutsar I, McCoig CC, Trujillo M, Wubbel L, Shelton S, McCracken GH Jr.

Antimicrob Agents Chemother. 1999 Apr;43(4):876-81.

18.

Etiology and treatment of community-acquired pneumonia in ambulatory children.

Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, Abramo T, Leinonen M, McCracken GH Jr.

Pediatr Infect Dis J. 1999 Feb;18(2):98-104.

PMID:
10048679
19.

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.

Lutsar I, Friedland IR, Wubbel L, McCoig CC, Jafri HS, Ng W, Ghaffar F, McCracken GH Jr.

Antimicrob Agents Chemother. 1998 Oct;42(10):2650-5.

Supplemental Content

Loading ...
Support Center